Taiwan Biomaterial Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 09, 2021
Share
Taiwan Biomaterial Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 19.75 million compared to TWD 2.92 million a year ago. Net loss was TWD 6.06 million compared to TWD 15.97 million a year ago. Basic loss per share from continuing operations was TWD 0.18 compared to TWD 0.48 a year ago. Diluted loss per share from continuing operations was TWD 0.18 compared to TWD 0.48 a year ago.
For the nine months, sales was TWD 34.9 million compared to TWD 5.01 million a year ago. Net loss was TWD 32.03 million compared to TWD 53.44 million a year ago. Basic loss per share from continuing operations was TWD 0.97 compared to TWD 1.62 a year ago. Diluted loss per share from continuing operations was TWD 0.97 compared to TWD 1.62 a year ago.
Taiwan Biomaterial Co., Ltd. is a Taiwan-based company mainly engaged in provision of medical equipment. The products are still in research and development stage. The Company's subsidiary TAIWAN MEDICAL RAPID PROTOTYPING CO., LTD.(TRP) is engaged in trial production of medical equipment. Main products include foam artificial meninges products, stroke thrombus aspiration catheter products, repair and regeneration products for early degenerative arthritis and others.
TAIWAN BIOMATERIAL CO., LTD. 
